Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Photocure ASA ( (PHCUF) ) has issued an update.
Photocure ASA has announced its annual general meeting scheduled for May 5, 2025, to be held virtually through the Euronext Securities Portal. Shareholders can participate by voting in advance or submitting a proxy, with all relevant documents available on the company’s website. This meeting underscores Photocure’s commitment to maintaining transparency and engaging with its stakeholders effectively.
More about Photocure ASA
Photocure ASA, known as The Bladder Cancer Company, specializes in providing transformative solutions for bladder cancer patients. Utilizing unique technology that highlights cancer cells in bright pink, Photocure has improved health outcomes globally. The company is based in Oslo, Norway, and is listed on the Oslo Stock Exchange.
YTD Price Performance: -18.80%
Average Trading Volume: 953
Technical Sentiment Signal: Strong Buy
Current Market Cap: $122.1M
Learn more about PHCUF stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue